1. A New Perspective

   • Michael R. Hamrell

   From the Editor-in-Chief 30 December 2005 Pages: 1 - 1

2. Assessing Risk and Benefit Communication in Direct-to-Consumer Medication Website Advertising

   • William J. Vigilante Jr.
   • Michael S. Wogalter

   Advertising and Communication 30 December 2005 Pages: 3 - 12

3. Examination of the Relationship between Direct-to-Consumer Advertising Expenditure and Price

   • Radhika Anantharaman
   • Anju Parthan
   • Marv Shepherd

   Advertising and Communication 30 December 2005 Pages: 13 - 24

4. Do Prescription Drug Advertisements Educate the Public? The Consumer Answers

   • Henry N. Young
   • Debora A. Paterniti
   • Richard L. Kravitz

   Advertising and Communication 30 December 2005 Pages: 25 - 33

5. Industry-Based Medical Communications: Benchmarking Survey of Quality Assurance Practices

   • S. Justin Hileman
   • Angie S. Graham
   • Barry Grobman

   Advertising and Communication 30 December 2005 Pages: 35 - 42

6. Evaluating Consumer Understanding of Two Patient Instructions for Use Inserts Provided by Manufacturers

   • Brent L. Rollins
   • Donald L. Sullivan

   Advertising and Communication 30 December 2005 Pages: 43 - 51

7. Development of a Charter for an Endpoint Assessment and Adjudication Committee

   • Steve Kradjian
   • John Gutheil
   • David C. Kaslow

   Clinical Trials 30 December 2005 Pages: 53 - 61

8. Erratum to: Unequal Center Sizes, Sample Size, and Power in Multicenter Clinical Trials

   • Francis Ruvuna

   Erratum 30 December 2005 Pages: 62 - 62

9. Adverse Event Analysis and MedDRA: Business as Usual or Challenge?

   • Jürgen Kübler
   • Richardus Vonk
   • Peter Voleske

   Pharmacovigilance/Safety 30 December 2005 Pages: 63 - 72

10. Adverse Incident Reporting for Medical Devices—A Comparison with Pharmacovigilance

    • David Jefferys

    Pharmacovigilance/Safety 30 December 2005 Pages: 73 - 80

11. Establishing an Adverse Event Collection Team in a Pharmaceutical Company Safety Department: Impact on Report Quality and Customer Satisfaction

    • Thomas Umrath
    • Alan L. Bess

    Pharmacovigilance/Safety 30 December 2005 Pages: 81 - 88

12. Development of Interactive Software for Bayesian Optimal Phase 1 Clinical Trial Design

    • William F. Rosenberger
    • Gerald C. Canfield
    • Petr Hausner

    Statistics 30 December 2005 Pages: 89 - 98

13. Responsible Self-Medication in Latin America

    • Héctor Bolaños

    Regulatory Affairs 30 December 2005 Pages: 99 - 107